STAAR Surgical Company (STAA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, STAAR Surgical Company (STAA) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.91K) by net assets ($344.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See STAAR Surgical Company liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
STAAR Surgical Company - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how STAAR Surgical Company's cash flow conversion efficiency has evolved over time, based on yearly financial data.
STAAR Surgical Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of STAAR Surgical Company ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanobiotix S.A
PA:NANO
|
0.253x |
|
China Yuchai International Limited
F:CYD
|
N/A |
|
Adecoagro S.A
F:ACD
|
0.095x |
|
Mota-Engil SGPS S.A
LS:EGL
|
0.095x |
|
Land and Houses Public Company Limited
BK:LH
|
0.015x |
|
Crombie Real Estate Investment Trust
TO:CRR-UN
|
0.041x |
|
Yelp Inc
NYSE:YELP
|
0.179x |
|
Guangzhou Wondfo Biotech Co Ltd
SHE:300482
|
0.021x |
Annual Cash Flow Conversion Efficiency for STAAR Surgical Company (1990–2025)
The table below shows the annual cash flow conversion efficiency of STAAR Surgical Company from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see how much is STAAR Surgical Company worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $344.18 Million | $-34.23 Million | -0.099x | -351.29% |
| 2024-12-31 | $397.33 Million | $15.72 Million | 0.040x | +4.66% |
| 2023-12-31 | $385.95 Million | $14.59 Million | 0.038x | -64.41% |
| 2022-12-31 | $336.11 Million | $35.72 Million | 0.106x | -37.50% |
| 2021-12-31 | $258.56 Million | $43.96 Million | 0.170x | +60.06% |
| 2020-12-31 | $197.22 Million | $20.95 Million | 0.106x | -34.16% |
| 2019-12-31 | $159.88 Million | $25.80 Million | 0.161x | +67.35% |
| 2018-12-31 | $132.43 Million | $12.77 Million | 0.096x | +45.09% |
| 2017-12-31 | $42.94 Million | $2.85 Million | 0.066x | +140.10% |
| 2016-12-31 | $37.91 Million | $1.05 Million | 0.028x | +149.72% |
| 2015-12-31 | $38.85 Million | $-2.16 Million | -0.056x | +74.03% |
| 2014-12-31 | $37.10 Million | $-7.95 Million | -0.214x | -348.41% |
| 2013-12-31 | $38.85 Million | $3.35 Million | 0.086x | -14.87% |
| 2012-12-31 | $31.74 Million | $3.22 Million | 0.101x | -44.15% |
| 2011-12-31 | $29.46 Million | $5.35 Million | 0.181x | +192.14% |
| 2010-12-31 | $22.43 Million | $-4.42 Million | -0.197x | -390.80% |
| 2009-12-31 | $21.07 Million | $1.43 Million | 0.068x | +113.19% |
| 2008-12-31 | $16.03 Million | $-8.23 Million | -0.513x | -66.29% |
| 2007-12-31 | $36.23 Million | $-11.18 Million | -0.309x | -13.40% |
| 2006-12-31 | $31.76 Million | $-8.65 Million | -0.272x | -57.54% |
| 2005-12-31 | $40.37 Million | $-6.98 Million | -0.173x | +25.68% |
| 2004-12-31 | $37.86 Million | $-8.80 Million | -0.233x | -98.67% |
| 2003-12-31 | $35.42 Million | $-4.15 Million | -0.117x | -730.49% |
| 2002-12-31 | $30.65 Million | $569.00K | 0.019x | +133.98% |
| 2001-12-31 | $46.83 Million | $-2.56 Million | -0.055x | +40.35% |
| 2000-12-31 | $58.67 Million | $-5.37 Million | -0.092x | -199.42% |
| 1999-12-31 | $53.20 Million | $4.90 Million | 0.092x | +4.10% |
| 1998-12-31 | $48.60 Million | $4.30 Million | 0.088x | -47.84% |
| 1997-12-31 | $44.80 Million | $7.60 Million | 0.170x | -26.95% |
| 1996-12-31 | $36.60 Million | $8.50 Million | 0.232x | +33.31% |
| 1995-12-31 | $28.70 Million | $5.00 Million | 0.174x | -4.18% |
| 1994-12-31 | $22.00 Million | $4.00 Million | 0.182x | +318.18% |
| 1993-12-31 | $12.00 Million | $-1.00 Million | -0.083x | +80.38% |
| 1992-12-31 | $7.30 Million | $-3.10 Million | -0.425x | +62.73% |
| 1991-12-31 | $4.30 Million | $-4.90 Million | -1.140x | -13.95% |
| 1990-12-31 | $100.00K | $-100.00K | -1.000x | -- |
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorde… Read more